Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-033055
Filing Date
2024-08-19
Accepted
2024-08-19 15:12:43
Documents
52
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1432578
2 ex10-70.htm EX-10.70 29756
3 ex10-71.htm EX-10.71 27290
4 ex31.htm EX-31 12931
5 ex32.htm EX-32 6941
6 ex10-71_001.jpg GRAPHIC 32824
7 ex10-71_002.jpg GRAPHIC 41610
8 ex10-71_003.jpg GRAPHIC 194602
9 ex10-71_004.jpg GRAPHIC 108915
10 ex10-71_005.jpg GRAPHIC 260087
  Complete submission text file 0001493152-24-033055.txt   6391267

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE clcs-20240630.xsd EX-101.SCH 29809
12 XBRL CALCULATION FILE clcs-20240630_cal.xml EX-101.CAL 35153
13 XBRL DEFINITION FILE clcs-20240630_def.xml EX-101.DEF 217426
14 XBRL LABEL FILE clcs-20240630_lab.xml EX-101.LAB 272320
15 XBRL PRESENTATION FILE clcs-20240630_pre.xml EX-101.PRE 239328
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 883302
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 241220094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)